Nordson is no longer waiting for the industrial cycle to rescue a mature adhesives franchise. The Westlake, Ohio company spent two years selling lower-value medical contract work, buying proprietary infusion components through Atrion, and waiting for electronics capital spending to turn. The fiscal third quarter is the first print where that rotation shows up as organic acceleration rather than mix cleanup. Sales set an all-time quarterly record, and organic growth of twelve percent ran ahead of the reported ten percent gain because the contract-manufacturing exit still subtracts from the top line.
The real story sits in Advanced Technology Solutions, the electronics dispense and inspection franchise. Organic sales in that segment jumped more than thirty percent, and segment earnings before interest, taxes, depreciation, and amortization expanded to thirty percent of sales from twenty-four percent a year earlier. That is operating leverage on a semiconductor and electronics upswing, not a price-list change. Medical and Fluid Solutions grew organically at a double-digit rate once the contract-manufacturing sale is stripped out, which is the mix upgrade working. Industrial Precision Solutions, still the largest slice, only crawled, and its margin slipped as the company spent to hold share in slower industrial and agricultural systems markets.
Management raised full-year sales and adjusted earnings after backlog climbed thirty-five percent and order entry stayed broad. The equity now prices Nordson as a growth compounder rather than a cyclical dispenser. The open question is whether Advanced Technology can stay well above its mid-single-digit algorithm once this electronics wave cools, or whether the multiple is already paying for a peak rate.